Thrombolysis in cardiac arrest;Trombolisis en la parada cardíaca

Medicina Intensiva

Volumn 30, Issue 2, 2006, Pages 62-67

  Ruiz Bailen M ^a,b   Rucabado Aguilar, L ^a   Morante Valle, A ^a   Castillo Rivera, A ^a  

^a Hospital Universitario Medico Quirurgico   (Spain)

^b NONE   (Spain)

Author keywords

Acute myocardial infarction; Cardiac arrest; Cardiopulmonary resuscitation; Pulmonary thromboembolism; Thrombolysis

Indexed keywords

ALTEPLASE; DEXTRAN; FIBRINOLYTIC AGENT; STREPTOKINASE;

BLEEDING; BLOOD CLOT LYSIS; CARDIOPULMONARY INSUFFICIENCY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HEART INFARCTION; HUMAN; LUNG EMBOLISM; NEUROLOGIC DISEASE; RESUSCITATION; REVIEW; RISK BENEFIT ANALYSIS; SAFETY;

EID: 33645789807     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(06)74470-9     Document Type: Review

References (35)

1. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-85.
2. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest. 1999;115:1695-707.
3. Jerjes-Sánchez C, Ramírez-Rivera A, de Lourdes García M, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995;2:227-9.
4. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341:507-11.
5. Come PC, Kim D, Parker JA, Goldhaber SZ, Braunwald E, Markis JE. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol. 1987;10:971-8.
6. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol. 1996;28:1328-428.
7. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 1996;17:43-63.
8. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
9. Renkes-Hegendorfer U, Hermann K. Successful treatment of a case of fulminant massive pulmonary embolism with streptokinase. Anaesthesist. 1974;23:500-1.
10. Borst RH, Wolf H. Rapid intravenous injection of streptokinase in a high initial dose for therapy of a fulminant pulmonary embolism. Anaesthesist. 1976;25:398-401.
11. Cross SJ, Lee HS, Rawles JM, Jennings K. Safety of thrombolysis in association with cardiopulmonary resuscitation. BMJ. 1991;303:1242.
12. Tenaglia AN, Califf RM, Candela RJ, Kereiakes DJ, Berrios E, Young SY, et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol. 1991;68:1015-9.
13. Scholz KH, Tebbe U, Herrmann C, Wojcik J, Lingen R, Chemnitius JM, et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol. 1992;69:724-8.
14. van Campen LC, van Leeuwen GR, Verheugt FW. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol. 1994;73:953-5.
15. Schieie R, Rustige J, Burczyk U, Koch A, Hamjanz D, Tebbe U, et al. Thrombolysis after resuscitation in acute myocardial infarction. J Am Coll Cardiol. 1996;27 Supl 1:279.
16. Ruiz Bailén M, Aguayo de Hoyos E, Serrano Corcoles MC, Díaz Castellanos MA, Ramos Cuadra JA, Reina Toral A. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med. 2001:27;1050-7.
17. Stewart BF, Weaver WD, Parsons LS. Reperfusion therapy after prehospital cardiac arrest and its influence on outcome alter acute myocardial infarction. J Am Coll Cardiol. 1996;27 Supl 1:278.
18. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation. 2001;50:71-6.
19. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glatzer R, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet. 2001;357:1583-5.
20. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial). Resuscitation. 2004;61:309-13.
21. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med. 2002;346:1522-8.
22. Ruiz Bailén M, Cuadra JA, Aguayo de Hoyos E. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism. A review. Critical Care Med. 2001;29:2211-9.
23. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 1995;108:227S-30.
24. Janata K, Holzer M, Kürkciyan I, Losert H, Riedmüller E, Pikula B, et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation. 2003;57:49-55.
25. Ruiz Bailén M, Aguayo de Hoyos E, Serrano Córcoles MC, Díaz Castellanos MA, Fierro Rosón JL, Ramos Cuadra JA, et al. Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. Resuscitation. 2001;51:97-101.
26. Spohr F, Bottiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf. 2003;26:367-79.
27. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care. 2004;10:208-12.
28. Fischer M, Hossmann KA. No-reflow after cardiac arrest. Intensive Care Med. 1995;21:132-41.
29. Böttiger BW, Motsch J, Bohrer H, Boker T, Aulmann M, Nawroth PP, et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation. 1995;92:2572-8.
30. Lin SR, O'Connor MJ, Fischer HW, King A. The effect of combined dextran and streptokinase on cerebral function and blood flow after cardiac arrest: an experimental study on the dog. Invest Radiol. 1978;13:490-8.
31. Gok MA, Shenton BK, Buckley PE, Peaston R, Cornell C, Soomro N, et al. How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors. Transplantation. 2003;76:1714-9.
32. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med. 1996;22:1214-23.
33. Kim YH, Park JH, Hong SH, Koh JY. Nonproteolytic neuroprotection y human recombinant tissue plasminogen activator. Science. 1999;284;647-50.
34. Schreiber W, Gabriel D, Sterz F, Muellner M, Kuerkciyan I, Holzer M, et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation. 2002;52:63-9.
35. http://www.boehringer-ingelheim.es/prensa/notas/031205. html.